Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia, Refractory × tipifarnib × Clear all

Sponsor

Conditions

Leukemia, Myelomonocytic, Acute 3 Leukemia, Myeloid, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Wilms Tumor 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1

Interventions

fludarabine phosphate 9 Cyclophosphamide 9 Whole-Body Irradiation 8 Mycophenolic Acid 8 Cyclosporine 8 Cord Blood Stem Cell Transplantation 8 Busulfan 4 fludarabine 3 Thiotepa 3 Tacrolimus 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Antilymphocyte Serum 3 Methotrexate 2 Decitabine 2 Cytarabine 2 Cyclosporins 2 vatalanib 1 poly ICLC 1 merphos 1 lintuzumab 1 Vorinostat 1 Nivolumab 1 Microarray Analysis 1 Methylprednisolone 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡